Professor Andrew M. Scott AM
Professor Andrew Scott AM
12th World Congress of the World Federation of Nuclear Medicine and Biology
20-24 April 2018
Professor Scott graduated in Medicine from the University of Sydney (MB BS, Hons), and trained in Internal Medicine, Nuclear Medicine and Tumour Immunology in Sydney, and at Memorial Sloan-Kettering Cancer Center, USA. His current appointments include Director, Department of Molecular Imaging and Therapy, Austin Health; Laboratory Head, Olivia Newton-John Cancer Research Institute; Professor, School of Cancer Medicine, La Trobe University; and Professor, Faculty of Medicine, University of Melbourne. His research is focused on developing innovative strategies for targeted therapy of cancer with monoclonal antibodies and cell signalling inhibition, and in oncology applications in PET, both in staging and molecular characterisation of tumours. Prof Scott has been involved in establishing and running a Phase I / II clinical trials program in recombinant antibodies and molecular imaging in cancer leading to 5 antibodies being licenced to Biotech and Pharma companies which are currently in Phase II/III clinical trials. In addition to being appointed from 2010 as a Member, Ambassador Program, Club Melbourne, Prof Scott is Chair of Cancer Trials Australia, on the Board of the Australian Nuclear Science and Technology Organisation (ANSTO) since 2007, and is immediate Past-President, World Federation of Nuclear Medicine & Biology.